Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 01, 2008. The document serves as a report of a foreign issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. It specifically discloses a notification of major interests in shares received from Legal & General Group plc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding shareholding interests rather than a financial performance report.
Material Changes
The material change disclosed is an acquisition or disposal of voting rights by Legal & General Group plc and its subsidiaries. As of July 30, 2008, the group's holdings resulted in a voting interest of below 5%.
- Shareholder: Legal & General Group plc (Group), Legal & General Investment Management Limited (LGIM), and Legal & General Assurance (Pensions Management) Limited (PMC).
- Transaction Date: July 30, 2008.
- Notification Date: July 31, 2008.
- Threshold Status: Below 5% for the Group and LGIM.
- Specific Holdings: Legal & General Group plc (Direct) holds 244,009,760 shares (4.65%). Legal & General Investment Management (Holdings) Limited (Direct) holds 200,360,654 shares (3.82%).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a notification of shareholding changes in accordance with DTR 5.8.12.
Investor Verification Points
- Verify the total voting rights figure used for the notification, stated as 5,240,433,283.
- Confirm the breakdown of direct and indirect holdings within the Legal & General Group structure.
- Note that the reported percentage of voting rights for the Group and LGIM remains below the 5% disclosure threshold.